| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/08/2001 | WO2001008707A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 02/08/2001 | WO2001008671A2 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | WO2000058307A3 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 02/08/2001 | WO2000058295A3 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 02/08/2001 | WO2000054758A3 Method for delivering benzidine prostaglandins by inhalation |
| 02/08/2001 | WO2000050455A3 Antigen to systemic lupus erythematosis and diagnostic assay |
| 02/08/2001 | DE19935302A1 Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen Conjugates and methods for their preparation and their use for transporting molecules across biological membranes |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380489A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | CA2379703A1 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073441A1 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) |
| 02/07/2001 | EP1073440A1 sPLA 2 INHIBITOR ESTER |
| 02/07/2001 | EP1073438A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO 5,6]CYCLOHEPTA 1,2-b]PYRIDINE ORAL COMPOSITIONS |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | EP1073429A1 Aerosol formulations of salmeterol xinafoate |
| 02/07/2001 | EP1073417A1 Pharmaceutical aerosol formulation |
| 02/07/2001 | CN1283184A Process for stereo selective synthesis of prostacyclin derivatives |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1283115A Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 02/07/2001 | CN1283106A Pharmaceutical compositions comprising micelles comprising lipophilic glucoiorticosteroid and only one surfactant |
| 02/07/2001 | CN1282737A Intermediate product used for preparing substituted quinoline-2-formamide |
| 02/07/2001 | CN1282601A Enqlish yew tea for making throat comfortable |
| 02/07/2001 | CN1282597A Chinese patent medicine for treating cold cough and its preparing process |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/07/2001 | CN1061652C Endotheliomycine receptor antagonist |
| 02/07/2001 | CN1061543C Compound pill for treating chronic bronchitis |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184231 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184217 Administering antiinflammatory dosage of a ring-substituted indolocarbazole derivative compound; tumor necrosis factor (tnf) inhibitors |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | CA2147807C Bicyclic-aromatic compounds; pharmaceutical and cosmetic compositions containing them and uses |
| 02/06/2001 | CA2024789C Compounds for the treatment of inflammation and allergy |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007441A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
| 02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007406A1 Novel amide derivatives |
| 02/01/2001 | WO2001007405A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | WO2001007072A1 Modulation of platelet activation |
| 02/01/2001 | WO2001007053A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 02/01/2001 | WO2001007050A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | WO2001007014A1 Formulations of steroid solutions for inhalatory administration |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000056359A3 Vaccine against streptococcus pneumoniae |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO2000043781A3 Growth differentiation factor inhibitors and uses therefor |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | DE19935771A1 Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with cyclic substructures in the side chains, to processes and intermediates for their preparation and to the use for the preparation of medicaments |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380181A1 8-phenyl-6,9-dihydro-¬1,2,4|triazolo¬3,4-i|purin-5-one derivatives |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379398A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | CA2378473A1 Modulation of platelet activation |
| 02/01/2001 | CA2376465A1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/31/2001 | EP1072597A1 Pyrazoles and their use as endothelin antagonists |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/31/2001 | EP1071646A1 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds |
| 01/31/2001 | EP1071645A1 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds |
| 01/31/2001 | EP1071474A1 Substituted porphyrins |
| 01/31/2001 | EP1071463A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 01/31/2001 | EP1071462A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 01/31/2001 | EP1071461A1 Methods and compositions using cetirizine in combination with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition |
| 01/31/2001 | EP1071440A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071417A1 Use of cannabinoids as anti-inflammatory agents |
| 01/31/2001 | EP1071405A1 Method for the treatment of asthma |
| 01/31/2001 | CN1282372A Mammalian sytokine-like polypeptide-10 |
| 01/31/2001 | CN1282321A Potassium channel openers |
| 01/31/2001 | CN1282254A Compositions and methods for regulating phagocytosis and ICAM-1 expression |
| 01/31/2001 | CN1282253A Small peptides and method for treatment of asthma and inflammation |
| 01/31/2001 | CN1282251A Method and material for treating and preventing mucosal tissue inflammation |
| 01/31/2001 | CN1282244A Pharmaceutical compositions |
| 01/31/2001 | CN1281703A Kechuan Xieling ointment |